Clinical Trial Update: Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2

View source ↗

Summary

This is a completed clinical trial update from Stanford University investigating the role of insulin resistance and FOXC2 in lymphedema associated with breast c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lymphedema

Snippet

Sponsor: Stanford University | Conditions: Lymphedema, Breast Cancer | Status: COMPLETED